+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Infection Drug"

From
Anti-Infectives - Global Strategic Business Report - Product Thumbnail Image

Anti-Infectives - Global Strategic Business Report

  • Report
  • February 2025
  • 116 Pages
  • Global
From
From
From
Chlamydia Infection Treatment Market Report 2024 - Product Thumbnail Image

Chlamydia Infection Treatment Market Report 2024

  • Report
  • September 2024
  • 175 Pages
  • Global
From
Chronic Pulmonary Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Pulmonary Infections - Pipeline Insight, 2024

  • Clinical Trials
  • December 2024
  • 60 Pages
  • Global
From
Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Pneumococcal infections - Pipeline Insight, 2024 - Product Thumbnail Image

Pneumococcal infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 75 Pages
  • Global
From
Hepatitis B Virus Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatitis B Virus Infection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Influenza virus B infections - Pipeline Insight, 2024 - Product Thumbnail Image

Influenza virus B infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Hepatitis Delta Virus (HDV) Infection - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Pseudomonal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Pseudomonal Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 50 Pages
  • Global
From
Complicated Intra-Abdominal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Complicated Intra-Abdominal Infections - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 60 Pages
  • Global
From
Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Nontuberculous Mycobacterial Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 60 Pages
  • Global
From
Staphylococcal Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Staphylococcal Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 80 Pages
  • Global
From
Surgery Incisional Infections - Pipeline Insight, 2024 - Product Thumbnail Image

Surgery Incisional Infections - Pipeline Insight, 2024

  • Drug Pipelines
  • July 2024
  • 60 Pages
  • Global
From
BK Virus (BKV) Infection - Pipeline Insight, 2024 - Product Thumbnail Image

BK Virus (BKV) Infection - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
From
Loading Indicator

The Infectious Diseases Drugs market is a subset of the pharmaceutical industry that focuses on the development and production of drugs used to treat infectious diseases. These drugs are used to treat a wide range of infections, including bacterial, viral, fungal, and parasitic infections. The market is highly competitive, with many companies vying for market share. Companies in the market are typically focused on developing new drugs, as well as improving existing treatments. Additionally, many companies are involved in the production of generic drugs, which are often cheaper than brand-name drugs. Companies in the Infectious Diseases Drugs market include Pfizer, Merck, GlaxoSmithKline, Sanofi, AstraZeneca, Novartis, Johnson & Johnson, and Bristol-Myers Squibb. Show Less Read more